key: cord-1043648-oohlrc6k
authors: Abayomi, Akin; Odukoya, Oluwakemi; Osibogun, Akin; Wright, Ololade; Adebayo, Bisola; Balogun, Mobolanle; Abdus-Salam, Ismael; Bowale, Abimbola; Mutiu, Bamidele; Saka, Babatunde; Adejumo, Moyosore; Yenyi, Sam; Agbolagorite, Rotimi; Onasanya, Oluwatosin; Erinosho, Eniola; Obasanya, Joshua; Adejumo, Olu; Adesola, Sunday; Oshodi, Yewande; Akase, Iorhen E.; Ogunbiyi, Shina; Lajide, Dayo; Erinoso, Femi; Abdur-Razzaq, Hussein
title: Presenting Symptoms and Predictors of Poor Outcomes Among 2,184 Patients with COVID-19 in Lagos State, Nigeria
date: 2020-10-16
journal: Int J Infect Dis
DOI: 10.1016/j.ijid.2020.10.024
sha: e8bac89d0ab90ae088a0ab0a685cb56dded7f36a
doc_id: 1043648
cord_uid: oohlrc6k

INTRODUCTION: Lagos state remains the epicentre of COVID-19 in Nigeria. We describe the symptoms and signs of the first 2,184 PCR-confirmed COVID-19 patients admitted at COVID-19 treatment centers in Lagos State. We also assessed the relationship between patients’ presenting symptoms, sociodemographic and clinical characteristics and COVID-19 deaths.. METHODS: Medical records of PCR-confirmed COVID-19 patients were extracted and analyzed for their symptoms, symptom severity, presence of comorbidities and outcome. RESULTS: The ages of the patients ranged from 4 days to 98 years with a mean of 43.0(16.0) years. Of the patients who presented with symptoms, cough (19.3%) was the most common presenting symptom. This was followed by fever (13.7%) and difficulty in breathing, (10.9%). The most significant clinical predictor of death was the severity of symptoms and signs at presentation. Difficulty in breathing was the most significant symptom predictor of COVID-19 death (OR:19.26 95% CI 10.95-33.88). The case fatality rate was 4.3%. CONCLUSION: Primary care physicians and COVID-19 frontline workers should maintain a high index of suspicion and prioritize the care of patients presenting with these symptoms. Community members should be educated on such predictors and ensure that patients with these symptoms seek care early to reduce the risk of deaths associated with COVID-19.

headache, sore throat, abdominal pain and diarrhea. Koh J et al 2020; Lapostolle et al 2020; Lechien et al 2020) There is limited research on the symptom profile of COVID-19 patients in Nigeria.

The first and only study in Nigeria that reported the symptomatology of COVID-19 in Lagos State found that admitted early cases of COVID-19 had an average age of 38.1 years, were mostly male and had moderately severe symptoms (66%), while only 16% were asymptomatic. 7 The validity of the findings of this study is limited by its small sample size (only 32 patients) and the fact that the data was obtained from a single isolation centre in Lagos state. (Bowale et al 2020) COVID-19 is a new and rapidly evolving disease. Understanding the symptoms profile of the infection is important in formulating a practicable approach to rapidly identify cases and assess the course of infection. This will improve treatment outcomes and reduce disease transmission and death rates. Assessing the relationship between symptom severity and COVID-19 outcomes may provide some insights into the understanding of the disease and its risk or protective factors. The objective of this study is to use data from a large cohort of the first 2184 patients with PCR confirmed COVID-19 admitted in nine isolation and treatment centres in Lagos State, to describe the pattern of symptoms and predictors of mortality from COVID-19. It is hoped that these findings will fill some critical gaps in research on COVID-19 in Nigeria and provide locally relevant evidence on COVID-19 among Nigerians. The findings will also inform state and national policy and decision-making to improve health outcomes for the rapidly rising number of COVID-19 patients in Nigeria.

The cases reported in this study were patients admitted at all of the nine treatment centres in Lagos state, Southwest Nigeria, though their places of residence were diverse in the Lagos Metropolis. Treatment centers refer to a place that provides in-patient hospital care specifically for COVID-19 cases.

This was a retrospective study using medical records of 2184 PCR confirmed COVID-19 patients. Laboratory confirmation of COVID-19 was done with nasooropharyngeal and sputum specimens that tested positive for the SARS-CoV-2 virus using realtime reverse transcription-polymerase-chain-reaction (RT-PCR) assay for SARS-CoV-2 in accordance with the protocol established by the World Health Organisation.(WHO 2020) Patients were considered negative and discharged after a negative PCR-based SARS-CoV-2 virus test. All patients were treated with Lopinavir-Ritonavir, Vitamin C, Vitamin D and Zinc.

J o u r n a l P r e -p r o o f Data extraction and analysis: Data were extracted from electronic medical records of the 2,184 patients as maintained by the case management teams at the hospital or isolation centres. We obtained data on patients age, gender, admitting facility, presenting symptoms, severity of initial presenting symptoms, the presence of co-morbidities and patient's final outcome (i.e. Dead or Discharged).

Patient's severity at presentation was based on clinical parameters and the need for oxygen and assisted ventilation. Mild patients are those who were asymptomatic at presentation; Moderate, if patient presented with fever, cough, respiratory rate <30breaths per minutes and peripheral capillary oxygen saturation (spO2) >90% for adults and >92% for children. A patient with grunting respiration, respiratory rate >30 breaths per minute, spO2 <90% for adults and <92% for children requiring oxygenation was classified as severe while a patient with respiratory failure requiring mechanical ventilation was classified as critical. Our case definition was adapted from a handbook on clinical experience in China (Yu 2020) STATA version 16 (StataCorp, USA) was used to conduct the data analysis.

Normally distributed continuous variables were presented as means (SD) while categorical variables were presented in tables as frequencies and percentages. To determine the variables associated with COVID-19 deaths, we first of all conducted a bivariate analysis using the student's T test and the Pearson's chi square tests for continuous or categorical variables respectively. Thereafter, we conducted two multivariable logistic regression models using variables that were significant at p<0.2. (Hosmer et al 2013 , Lee et al 2014 The first model was designed to determine the socio-demographic and clinical predictors of COVID19 death, while the second model was designed to identify the presenting symptoms most predictive of COVID-19 death among our COVID-19 patients. Variables that were collinear were dropped from the analysis. Results were presented in adjusted odds ratios and 95% confidence intervals. p values of <0.05 were considered statistically significant.

Ethics: Ethical approval was obtained from the Health Research and Ethics Committee of the Lagos State University Teaching Hospital. All patient data was anonymized and handled only by authorized personnel in order to ensure confidentiality.

Data from two thousand one hundred and eighty-four (2,184) laboratory confirmed COVID-19 patients presenting in nine treatment facilities in Lagos state. The ages of the patients ranged from 4 days to 98 years with a mean of 43.0(SD16.0) years. More than half (53.2%) were aged between 30 and 50 years. Only 2.9 % were children i.e. less than 18 years of age) while 3.8% were aged 70 years and older. The patients were mostly male (65.8%) and seen in in government owned COVID-19 treatment facilities (97%). More than half (57.5%) were tested within a hospital setting while 42.4% were tested at designated ambulatory centreand thereafter referred to the isolaton and treatment centres.

At presentation, majority were considered to have mild disease, while 6.8% of them were either in severe or critical condition at presentation. Less than a quarter (22.5%) presented with at least one other comorbidity. Of these, 25.4% presented with more than one comorbidity. The cases fatality rate was 4.3%.(Tables 1& 2)

Of the patients who presented with symptoms, cough (19.3%) was the most common presenting symptom. This was followed by fever (13.7%), difficulty in breathing, (10.9%) headaches (7.3%), weakness (6.3%), loss of sense of smell and taste (4.9%), throat irritation (4.9%), chest pain (3.8%), body pains (3.2%), nasal congestion (2.4%) and diarrhea (2.4%). All other symptoms were experienced by less than 1% of the patients. Figure 1 displays symptoms profile of patients. We report all symptoms that were presented by at least 2 patients. All other symptoms were presented by only one patient and include: hoarse voice, tooth pain, easy satiety, dry mouth, dark urine, frequent urination, stained mucus, body rash, bleeding, hemiparesis, increased thirst, hiccups, hearing impairment, metallic taste, swollen feet, leg shaking, tingling sensations, anorexia, osteoarthritis, vaginal discharge, weight loss, anxiety, convulsion, ear heaviness, excessive sweating, constipation and body itching

The bivariate analysis showed that more deaths occurred among older patients, males and patients admitted in non-government treatment facilities (p<0.05). Also, more deaths occurred in patients who were considered as being severe or critical at presentation also had more deaths.

More deaths also occurred in persons with existing co-morbidities and this increased with increasing number of co-morbidities. The most significant predictor of death was the severity of initial presentation. Patients presenting in a severe/critical state were 153 times more likely to have J o u r n a l P r e -p r o o f died (95%CI:30.74-766.35) while those presenting in a moderate state were 6.33 times (95%CI: 

This is the first study that reports the pattern of presenting symptoms and predictors of death among a large cohort of PCR confirmed COVID-19 patients in Nigeria, and one of the first in sub Saharan Africa. COVID-19 patients with dyspnea may have a higher risk of severe and critical disease outcomes. In our study, difficulty in breathing was the most significant predictive symptom More than half (58.3%) of patients in our study were asymptomatic and often reluctant to be admitted into isolation units. These patients though asymptomatic, can transmit the virus to others and as a result serve as an important source of hospital and community-based transmission. Two separate reviews of asymptomatic SARS-CoV-2 infections report slightly lower figures, ranging from 1.6% to 51.8% in the first review and 40%-45% of asymptomatic cases in the second review. 

To our knowledge, this is the first study in Nigeria and one of the first in sub Saharan Africa to explore the symptomatology and predictors of mortality using data from a large cohort of COVID 19 patients in several treatment facilities. It however has some important limitations and the findings should be interpreted with some caution. First, data on symptoms was obtained by self-report and may be subject to recall or reporting bias. Secondly, inferences on causality cannot be made due to the cross-sectional nature of data extraction.

Thirdly, this represents finding from the early stages of a dynamic and rapidly changing pandemic and the evidence provided may change over time or as more data becomes available.

Nevertheless, this study provides valuable evidence on the symptom profile and predictors of mortality for COVID-19 at a time where evidence from African countries is sparse.

Conclusion: Respiratory symptoms i.e. cough and difficulty in breathing, as well as fever are the most common presenting symptoms for the COVID-19 patients in our study. Difficulty in breathing is the most important symptom predictive of COVID-19 death. Body weakness and cough are also predictive symptoms of poor outcomes.. Severe symptoms at presentation, which may be brought about by late presentation, is the most significant predictor of death. Males, patients with coexisting morbidities and increasing age have poorer COVID-19 outcomes. Primary care physicians and COVID-19 frontline workers should maintain a high index of suspicion and prioritize the care of patients presenting with these symptoms. Emphasis should be placed on older males with comorbid conditions. Community members should ensure that patients with these symptoms seek care early to reduce the risk of deaths associated with COVID-19.

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. 

Late presentation of patients with cervical cancer to a tertiary hospital in Lagos: what is responsible

Prevalence and pattern of late-stage presentation in women with breast and cervical cancers in Lagos University Teaching Hospital

Clinical presentation, case management and outcomes for the first 32 COVID-19 patients in Nigeria. The Pan African Medical Journal

Clinical features, laboratory findings and predictors of death in hospitalized patients with COVID-19 in Sardinia, Italy

Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study

Predictors of Adverse Prognosis in Covid-19: A Systematic Review and Meta-analysis

A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: an observational cohort study

A systematic review of asymptomatic infections with COVID-19

Applied logistic regression

Older age and comorbidity are independent mortality predictors in a large cohort of 1305 COVID-19 patients in Michigan, United States

COVID-19: Review of Epidemiology and Potential Treatments Against

Clinical characteristics of asymptomatic and symptomatic patients with mild COVID-19

Epidemiological and Clinical Characteristics of Cases During the Early Phase of COVID-19 Pandemic: A Systematic Review and Meta-Analysis. Frontiers in Medicine

Asymptomatic patients as a source of COVID-19 infections: A systematic review and meta-analysis

Clinical features of 1487 COVID-19 patients with outpatient management in the Greater Paris: the COVID-call study. Internal and Emergency Medicine

Clinical and epidemiological characteristics of 1,420 European patients with mild-to-moderate coronavirus disease 2019

Should we adjust for a confounder if empirical and theoretical criteria yield contradictory results? A simulation study

Prevalence and duration of acute loss of smell or taste in COVID-19 patients

Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19

Smell dysfunction: a biomarker for COVID-19. InInternational forum of allergy & rhinology

Nigeria Centre for Disease Control Coronavirus COVID-19 Microsite

The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua liu xing bing xue za zhi= Zhonghua liuxingbingxue zazhi

Pathophysiological basis and rationale for early outpatient treatment of SARS-CoV-2 (COVID-19) Infection. The American journal of medicine

Disconnect between mcomunity testing and hospitalization for SARS-CoV-2 (COVID-19) infection. Proc (Bayl Univ Med Cent)

Evolutionary trends of the COVID-19 epidemic and effectiveness of government interventions in Nigeria: A data-driven analysis. medRxiv

Prevalence of Asymptomatic SARS-CoV-2 Infection: A Narrative Review

Health-seeking preferences of residents of Mushin LGA, Lagos: A survey of preferences for provision of maternal and child health services

A review of coronavirus disease-2019 (COVID-19). The Indian Journal of Pediatrics

Characteristics of COVID-19 infection in Beijing

Prostate cancer screening: what do men know, think and do about their risk? exploring the opinions of men in an urban area in Lagos State

Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up

World Health Organization. WHO/Europe | Coronavirus disease (COVID-19) outbreak -Health care considerations for older people during COVID-19 pandemic

PDF) Handbook of COVID-19 Prevention and Treatment